Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 22 results

Author Title Type [ Year

]

Filters: Author is Enama, Mary E [Clear All Filters]

2019

Carter, Cristina, Katherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, Jeanine May, Mary E Enama, Uzma Sarwar, et al.. 2019. “Safety And Immunogenicity Of Investigational Seasonal Influenza Hemagglutinin Dna Vaccine Followed By Trivalent Inactivated Vaccine Administered Intradermally Or Intramuscularly In Healthy Adults: An Open-Label Randomized Phase 1 Clinical Trial.”. Plos One 14 (9). Plos One: e0222178. doi:10.1371/journal.pone.0222178.

2018

Houser, Katherine V, Galina V Yamshchikov, Abbie R Bellamy, Jeanine May, Mary E Enama, Uzma Sarwar, Brenda Larkin, et al.. 2018. “Dna Vaccine Priming For Seasonal Influenza Vaccine In Children And Adolescents 6 To 17 Years Of Age: A Phase 1 Randomized Clinical Trial.”. Plos One 13 (11). Plos One: e0206837. doi:10.1371/journal.pone.0206837.

2017

Ledgerwood, Julie E, Adam D DeZure, Daphne A Stanley, Emily E Coates, Laura Novik, Mary E Enama, Nina M Berkowitz, et al.. 2017. “Chimpanzee Adenovirus Vector Ebola Vaccine.”. N Engl J Med 376 (10). N Engl J Med: 928-938. doi:10.1056/NEJMoa1410863.

2015

Ledgerwood, Julie E, Abbie R Bellamy, Robert Belshe, David I Bernstein, Srilatha Edupuganti, Shital M Patel, Phyllis Renehan, et al.. 2015. “Dna Priming For Seasonal Influenza Vaccine: A Phase 1B Double-Blind Randomized Clinical Trial.”. Plos One 10 (5). Plos One: e0125914. doi:10.1371/journal.pone.0125914.

Crank, Michelle C, Ingelise J Gordon, Galina V Yamshchikov, Sandra Sitar, Zonghui Hu, Mary E Enama, LaSonji A Holman, et al.. 2015. “Phase 1 Study Of Pandemic H1 Dna Vaccine In Healthy Adults.”. Plos One 10 (4). Plos One: e0123969. doi:10.1371/journal.pone.0123969.

Sarwar, Uzma N, Pamela Costner, Mary E Enama, Nina Berkowitz, Zonghui Hu, Cynthia S Hendel, Sandra Sitar, et al.. 2015. “Safety And Immunogenicity Of Dna Vaccines Encoding Ebolavirus And Marburgvirus Wild-Type Glycoproteins In A Phase I Clinical Trial.”. J Infect Dis 211 (4). J Infect Dis: 549-57. doi:10.1093/infdis/jiu511.

Kibuuka, Hannah, Nina M Berkowitz, Monica Millard, Mary E Enama, Allan Tindikahwa, Arthur B Sekiziyivu, Pamela Costner, et al.. 2015. “Safety And Immunogenicity Of Ebola Virus And Marburg Virus Glycoprotein Dna Vaccines Assessed Separately And Concomitantly In Healthy Ugandan Adults: A Phase 1B, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.”. Lancet 385 (9977). Lancet: 1545-54. doi:10.1016/S0140-6736(14)62385-0.

2014

Sarwar, Uzma N, Laura Novik, Mary E Enama, Sarah A Plummer, Richard A Koup, Martha C Nason, Robert T Bailer, et al.. 2014. “Homologous Boosting With Adenoviral Serotype 5 Hiv Vaccine (Rad5) Vector Can Boost Antibody Responses Despite Preexisting Vector-Specific Immunity In A Randomized Phase I Clinical Trial.”. Plos One 9 (9). Plos One: e106240. doi:10.1371/journal.pone.0106240.

Enama, Mary E, Julie E Ledgerwood, Laura Novik, Martha C Nason, Ingelise J Gordon, LaSonji Holman, Robert T Bailer, et al.. 2014. “Phase I Randomized Clinical Trial Of Vrc Dna And Rad5 Hiv-1 Vaccine Delivery By Intramuscular (I.m.), Subcutaneous (S.c.) And Intradermal (I.d.) Administration (Vrc 011).”. Plos One 9 (3). Plos One: e91366. doi:10.1371/journal.pone.0091366.

Chang, Lee-Jah, Kimberly A Dowd, Floreliz H Mendoza, Jamie G Saunders, Sandra Sitar, Sarah H Plummer, Galina Yamshchikov, et al.. 2014. “Safety And Tolerability Of Chikungunya Virus-Like Particle Vaccine In Healthy Adults: A Phase 1 Dose-Escalation Trial.”. Lancet 384 (9959). Lancet: 2046-52. doi:10.1016/S0140-6736(14)61185-5.

2013

Graham, Barney S, Mary E Enama, Martha C Nason, Ingelise J Gordon, Sheila A Peel, Julie E Ledgerwood, Sarah A Plummer, et al.. 2013. “Dna Vaccine Delivered By A Needle-Free Injection Device Improves Potency Of Priming For Antibody And Cd8+ T-Cell Responses After Rad5 Boost In A Randomized Clinical Trial.”. Plos One 8 (4). Plos One: e59340. doi:10.1371/journal.pone.0059340.

Ledgerwood, Julie E, Kathryn Zephir, Zonghui Hu, Chih-Jen Wei, Leejah Chang, Mary E Enama, Cynthia S Hendel, et al.. 2013. “Prime-Boost Interval Matters: A Randomized Phase 1 Study To Identify The Minimum Interval Necessary To Observe The H5 Dna Influenza Vaccine Priming Effect.”. J Infect Dis 208 (3). J Infect Dis: 418-22. doi:10.1093/infdis/jit180.

Seder, Robert A, Lee-Jah Chang, Mary E Enama, Kathryn L Zephir, Uzma N Sarwar, Ingelise J Gordon, LaSonji A Holman, et al.. 2013. “Protection Against Malaria By Intravenous Immunization With A Nonreplicating Sporozoite Vaccine.”. Science 341 (6152). Science: 1359-65. doi:10.1126/science.1241800.

Casazza, Joseph P, Kathryn A Bowman, Selorm Adzaku, Emily C Smith, Mary E Enama, Robert T Bailer, David A Price, et al.. 2013. “Therapeutic Vaccination Expands And Improves The Function Of The Hiv-Specific Memory T-Cell Repertoire.”. J Infect Dis 207 (12). J Infect Dis: 1829-40. doi:10.1093/infdis/jit098.

2011

Ledgerwood, Julie E, Chih-Jen Wei, Zonghui Hu, Ingelise J Gordon, Mary E Enama, Cynthia S Hendel, Patrick M McTamney, et al.. 2011. “Dna Priming And Influenza Vaccine Immunogenicity: Two Phase 1 Open Label Randomised Clinical Trials.”. Lancet Infect Dis 11 (12). Lancet Infect Dis: 916-24. doi:10.1016/S1473-3099(11)70240-7.

Ledgerwood, Julie E, Theodore C Pierson, Sarah A Hubka, Niraj Desai, Steve Rucker, Ingelise J Gordon, Mary E Enama, et al.. 2011. “A West Nile Virus Dna Vaccine Utilizing A Modified Promoter Induces Neutralizing Antibody In Younger And Older Healthy Adults In A Phase I Clinical Trial.”. J Infect Dis 203 (10). J Infect Dis: 1396-404. doi:10.1093/infdis/jir054.

2010

Koup, Richard A, Mario Roederer, Laurie Lamoreaux, Jennifer Fischer, Laura Novik, Martha C Nason, Brenda D Larkin, et al.. 2010. “Priming Immunization With Dna Augments Immunogenicity Of Recombinant Adenoviral Vectors For Both Hiv-1 Specific Antibody And T-Cell Responses.”. Plos One 5 (2). Plos One: e9015. doi:10.1371/journal.pone.0009015.

2008

Martin, Julie E, Mark K Louder, LaSonji A Holman, Ingelise J Gordon, Mary E Enama, Brenda D Larkin, Charla A Andrews, et al.. 2008. “A Sars Dna Vaccine Induces Neutralizing Antibody And Cellular Immune Responses In Healthy Adults In A Phase I Clinical Trial.”. Vaccine 26 (50). Vaccine: 6338-43. doi:10.1016/j.vaccine.2008.09.026.

2007

Catanzaro, Andrew T, Mario Roederer, Richard A Koup, Robert T Bailer, Mary E Enama, Martha C Nason, Julie E Martin, et al.. 2007. “Phase I Clinical Evaluation Of A Six-Plasmid Multiclade Hiv-1 Dna Candidate Vaccine.”. Vaccine 25 (20). Vaccine: 4085-92. doi:10.1016/j.vaccine.2007.02.050.

Parrino, Janie, Lewis H McCurdy, Brenda D Larkin, Ingelise J Gordon, Steven E Rucker, Mary E Enama, Richard A Koup, et al.. 2007. “Safety, Immunogenicity And Efficacy Of Modified Vaccinia Ankara (Mva) Against Dryvax Challenge In Vaccinia-Naïve And Vaccinia-Immune Individuals.”. Vaccine 25 (8). Vaccine: 1513-25. doi:10.1016/j.vaccine.2006.10.047.

2006

Catanzaro, Andrew T, Richard A Koup, Mario Roederer, Robert T Bailer, Mary E Enama, Zoe Moodie, Lin Gu, et al.. 2006. “Phase 1 Safety And Immunogenicity Evaluation Of A Multiclade Hiv-1 Candidate Vaccine Delivered By A Replication-Defective Recombinant Adenovirus Vector.”. J Infect Dis 194 (12). J Infect Dis: 1638-49. doi:10.1086/509258.

Graham, Barney S, Richard A Koup, Mario Roederer, Robert T Bailer, Mary E Enama, Zoe Moodie, Julie E Martin, et al.. 2006. “Phase 1 Safety And Immunogenicity Evaluation Of A Multiclade Hiv-1 Dna Candidate Vaccine.”. J Infect Dis 194 (12). J Infect Dis: 1650-60. doi:10.1086/509259.